Description
Synthetic Peptide for Immune Bioregulator Research
Technical Overview
Vilon 20mg is a synthetic peptide compound developed for laboratory research involving thymic gene expression and short-peptide bioregulator activity, receptor interaction analysis, and controlled experimental investigation. In research settings, this peptide is commonly utilized for studying lymphocyte signaling, immune-related transcription factor activity, and related biochemical mechanisms.
Vilon is one of the simplest Khavinson-class short-peptide bioregulators, consisting of the dipeptide L-Lys-L-Glu (KE). Within the Khavinson framework, this dipeptide is associated with thymic and immune-tissue modulation and is hypothesized to interact with chromatin in a sequence-specific manner.
Investigators use Vilon in thymocyte and lymphocyte culture models to study tissue-specific gene-regulation hypotheses, immune bioregulator pharmacology, and dipeptide-DNA interaction frameworks. It serves as a reference compound in comparative studies with other short-peptide bioregulators such as Epithalon and Vesugen.
This compound is synthesized using established solid-phase peptide synthesis methods and purified through reversed-phase HPLC to achieve analytical purity suitable for laboratory assays, binding studies, and analytical applications. The lyophilized material is supplied for reconstitution per established laboratory protocols and is intended as a reference material in controlled research environments.
Specifications
Compound Name: Vilon
Strength: 20mg
Purity: ≥ 99% (HPLC Verified)
Appearance: Lyophilized Peptide Powder
Format: Research Compound
Reconstitution: Suitable for laboratory assay preparation.
Notice
Provided as a reference material for scientific investigation only.
Reviews
There are no reviews yet.